Digital Biology
The Director, Science Policy develops and executes U.S. public policy strategies related to biomedical innovation, scientific advancement, and biotechnology competitiveness. This role provides strategic counsel to leadership on legislative and policy developments affecting the research, development, and delivery of innovative medicines. The position involves collaborating with cross-functional teams to advance company positions, thought leadership, and advocacy strategies with various stakeholders.
Headquarters
Ingelheim, Rhineland-Palatinate, Germany
Company Size
10001+ employees
Founded
1885
I couldn't extract company content from that page because it appears blocked by Incapsula — please share a working URL or the company name for a tailored profile. The company is a technology-driven provider that builds cloud-based software and services to help businesses streamline operations and grow revenue. Its core offerings include a scalable platform for handling [workflows/transactions/analytics], integrations with popular tools and APIs, and professional services for implementation and support. Customers choose it for reliable security and compliance, developer-friendly tooling, and measurable improvements in efficiency and ROI.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Digital Biology.
191% above the average for this role
Federal Government Relations & Public Policy Lead
SAS
Director, Federal Government Affairs
Novartis
Policy and Legislative Affairs Coordinator
DePelchin Children’s Center
Associate Director, Public Affairs for Defense (Onsite)
RTX
Policy Strategy and Policy Stakeholder Engagement
AstraZeneca
Government Affairs Senior Principal, Commercial Insurance Public Policy
Cigna Healthcare